← back to search

Zhenghao Wang

Shenyang Agricultural University · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Kidney Stones and Urolithiasis Treatments, Hip and Femur Fractures, Orthopaedic implants and arthroplasty, and MicroRNA in disease regulation.
h-index
18
citations
1,002
works
76
NIH funding
primary concept
email

Recent publications

Biodegradable and Antioxidant DNA Hydrogel as a Cytokine Delivery System for Diabetic Wound Healing
Advanced Healthcare Materials 2022cited by 101position: firstdoi
Physically Cross-Linked DNA Hydrogel-Based Sustained Cytokine Delivery for <i>In Situ</i> Diabetic Alveolar Bone Rebuilding
ACS Applied Materials & Interfaces 2022cited by 60position: middledoi
A DNA Nanoraft-Based Cytokine Delivery Platform for Alleviation of Acute Kidney Injury
ACS Nano 2021cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chengshi Wang · Sichuan University2 papers (2022–2022)Jiaye Liu · Beijing University of Technology2 papers (2022–2022)Ge Peng · Guangxi University of Science and Technology2 papers (2022–2022)Xianghui Fu · Jishou University2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022)Xiaofeng Zheng · Wenzhou Medical University2 papers (2022–2022)Ye Zhou · Zhejiang Chinese Medical University2 papers (2022–2022)Ruoqing Li · Chongqing University2 papers (2022–2022)Yuan‐Ping Han · Shanghai Medical College of Fudan University2 papers (2022–2022)Per‐Olof Berggren · Max Planck Institute for Metabolism Research2 papers (2022–2022)Wei Li · University of Science and Technology of China2 papers (2022–2022)Wanli Zhang · Fudan University2 papers (2022–2022)Min Zhu · Nantong University1 papers (2022–2022)Erwin Ilegems · Novo Nordisk (Denmark)1 papers (2022–2022)Qi Cao · The University of Sydney1 papers (2022–2022)Hong Su · Anhui Medical University1 papers (2022–2022)Yanrong Lu · Jilin University1 papers (2022–2022)Yali Tian · Michigan State University1 papers (2022–2022)